140
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Effectiveness of low dose of rapamycin in preventing seizure-induced anxiety-like behaviour, cognitive impairment, and defects in neurogenesis in developing rats

, , , , , , & show all
Pages 9-18 | Received 16 Feb 2017, Accepted 21 May 2018, Published online: 10 Oct 2019

References

  • Sands TT, McDonough TL. Recent advances in neonatal seizures. Curr Neurol Neurosci Rep. 2016;16(10):92.
  • Pisani F, Spagnoli C. Neonatal seizures: a review of outcomes and outcome predictors. Neuropediatrics. 2016;47(1):12–9.
  • Rakhade SN, Zhou C, Aujla PK, et al. Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J Neurosci. 2008;28(32):7979–90.
  • Kang SK, Kadam SD. Neonatal seizures: impact on neurodevelopmental outcomes. Front Pediatr. 2015;3:101.
  • Uria-Avellanal C, Marlow N, Rennie JM. Outcome following neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):224–32.
  • Silverstein FS, Jensen FE. Neonatal seizures. Ann Neurol. 2007;62(2):112–20.
  • Rodriguez-Alvarez N, Jimenez-Mateos EM, Dunleavy M, et al. Effects of hypoxia-induced neonatal seizures on acute hippocampal injury and later-life seizure susceptibility and anxiety-related behavior in mice. Neurobiol. Dis. 2015;83:100–14.
  • Parker AK, Le MM, Smith TS, et al. Neonatal seizures induced by pentylenetetrazol or kainic acid disrupt primary cilia growth on developing mouse cortical neurons. Experiment Neurol. 2016;282:119–27.
  • Sankar R, Painter MJ. Neonatal seizures: after all these years we still love what doesn’t work. Neurology. 2005;64(5):776–7.
  • Bartha AI, Shen J, Katz KH, et al. Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol. 2007;37(2):85–90.
  • Forcelli PA, Janssen MJ, Stamps LA, et al. Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure. Epilepsia. 2010;51(Suppl 3):18–23.
  • Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–93.
  • Crino PB. The mTOR signalling cascade: paving new roads to cure neurological disease. Nature reviews. Neurology. 2016;12(7):379–92.
  • Takei N, Nawa H. mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neurosci. 2014;7:28.
  • Hoeffer CA, Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 2010;33(2):67–75.
  • Zeng LH, Xu L, Gutmann DH, et al. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol. 2008;63(4):444–53.
  • Zeng LH, Rensing NR, Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci. 2009;29(21):6964–72.
  • Buckmaster PS, Ingram EA, Wen X. Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. J Neurosci. 2009;29(25):8259–69.
  • Huang X, Zhang H, Yang J, et al. Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiol Dis. 2010;40(1):193–9.
  • Sunnen CN, Brewster AL, Lugo JN, et al. Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice. Epilepsia. 2011;52(11):2065–75.
  • Brewster AL, Lugo JN, Patil VV, et al. Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage. PloS One. 2013;8(3):e57808.
  • Talos DM, Sun H, Zhou X, et al. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PloS One. 2012;7(5):e35885.
  • Raffo E, Coppola A, Ono T, et al. A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis. 2011;43(2):322–9.
  • Chachua T, Poon KL, Yum MS, et al. Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats. Epilepsia. 2012;53(11):2015–25.
  • Lu Z, Liu F, Chen L, et al. Effect of chronic administration of low dose rapamycin on development and immunity in young rats. PloS One. 2015;10(8):e0135256.
  • Chen LL, Feng HF, Mao XX, et al. One hour of pilocarpine-induced status epilepticus is sufficient to develop chronic epilepsy in mice, and is associated with mossy fiber sprouting but not neuronal death. Neurosci Bull. 2013;29(3):295–302.
  • Wu ML, Yang XJ, Liu FR, et al. Effective dosage of sirolimus for seizure treatment of immature C57BL/6 mice induced by kainic acid. Chin J Pharmacol Toxicol. 2017;31(1): 51–8.
  • Shi XY, Sun RP, Wang JW. Consequences of pilocarpine-induced recurrent seizures in neonatal rats. Brain Dev. 2007;29(3):157–63.
  • Castelhano AS, Ramos FO, Scorza FA, et al. Early life seizures in female rats lead to anxiety-related behavior and abnormal social behavior characterized by reduced motivation to novelty and deficit in social discrimination. J Neural Transm. 2015;122(3):349–55.
  • Huang X, McMahon J, Huang Y. Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy. Neuroscience. 2012;215:90–7.
  • Lin TC, Huang LT, Huang YN, et al Neonatal status epilepticus alters prefrontal-striatal circuitry and enhances methamphetamine-induced behavioral sensitization in adolescence. Epilepsy Behav. 2009;14(2):316–23.
  • Folbergrova J, Jesina P, Kubova H, et al Status epilepticus in immature rats is associated with oxidative stress and mitochondrial dysfunction. Front Cell Neurosci. 2016;10:136.
  • Suchomelova L, Lopez-Meraz ML, Niquet J, et al Hyperthermia aggravates status epilepticus-induced epileptogenesis and neuronal loss in immature rats. Neuroscience. 2015;305:209–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.